To provide the information your oncologist is not telling you or doesn't have the time to!
Navigating the complex realm of oncology often involves a blend of clinical expertise, investigative curiosity, and intuitive sensitivity. A recent encounter with a patient, previously diagnosed with a sizable axillary adenopathy considered “benign”, reinforces the necessity of approaching medical puzzles with an open mind and meticulous attention to detail. Earlier this year, a patient was …
Hematologists play a pivotal role in addressing various non-cancerous hematological conditions, alleviating patient concerns about being associated solely with cancer care. Many patients are unaware that hematologists are involved in treating a range of benign conditions, including: 1. Anemia: Anemia, characterized by low hemoglobin levels, can stem from various causes such as iron deficiency, inadequate …
One of the most vivid metaphors for chemotherapy is that of a bomb: it obliterates both good and bad cells, with the hope that only the good ones regenerate. While traditional chemotherapy remains a significant tool in cancer treatment, there’s been a recent shift towards more precise therapies that selectively target cancer cells. In the …
In a recent heartfelt letter to viewers, esteemed news anchor Greg Warmoth bravely opened about his lip cancer diagnosis. This news serves as a reminder of the importance of raising awareness about this particular form of cancer, its typical prognosis, available treatment options, and preventive measures that can be taken. Understanding Lip Cancer: Cutaneous squamous cell cancer is a relatively …
Here’s an interested case of a patient with MCC that I saw this past week. While I’d like to consider systemic immunotherapy with PD1 or dual checkpoint inhibitors, chemotherapy, clinical trial with MDNA or TLR9 agonist/PD1, this patient’s disease was limited to the skin alone. Could we do something different and perhaps with less risk …
Dr Landau led the Telehealth initiative at the Orlando Health Cancer Institute which became a proven necessity for our patient population not only at the peak of the pandemic but to this very day. Envisioning a future where expert-level healthcare is accessible to individuals regardless of their location, the concept of telehealth has emerged as …
Navigating the tumultuous waters of a cancer diagnosis can be a daunting task for any patient. Add to this a significant cardiac issue or a serious neurological complication, and the situation becomes even more intricate. This delicate dance, where life-threatening conditions intersect, highlights the need for truly multidisciplinary care. It’s a timely reminder that medicine …
This is a new clinical trial using Tebentafusp alone or in combination with Pembrolizumab is now open and actively enrolling at the Orlando Health Cancer Institute for patients dealing with Metastatic Cutaneous Melanoma. Tebentafusp is currently FDA approved for all patients with Metastatic Uveal Melanoma. Detailed information can be found here at clinicaltrials.gov and NEJM …
Navigating the course of cancer treatment is akin to venturing through challenging terrains, with medications forming essential waypoints on this journey. However, these waypoints—while indispensable—often come with hurdles in the form of side effects. In this post, we aim to equip you with actionable insights and approaches to handle these common challenges that accompany cancer …
Article written by one of our Melanoma/Sarcoma Clinical Trial Coordinators Chloe Caldwell to a target audience of healthcare providers regarding a new ongoing protocol for patients dealing with GIST open globally and at the Orlando Health Cancer Institute. All information posted here is publicly available here. Gastrointestinal Stromal Tumors (GIST) constitute a category of soft …